LifeStance Health Group, Inc. (LFST)

NASDAQ: LFST · IEX Real-Time Price · USD

5.50

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

5.54

+0.04 (0.73%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

LifeStance Health Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Revenue	1,104	1,056	859.54	667.51	212.52
Revenue Growth (YoY)	21.39%	22.82%	28.77%	214.10%	-
Cost of Revenue	776.29	753.57	622.53	466	150.12
Gross Profit	327.22	302.1	237.02	201.51	62.4
Selling, General & Admin	415.1	410.79	377.99	433.73	41.06
Other Operating Expenses	83.93	80.44	69.2	54.14	6.1
Operating Expenses	499.03	491.23	447.19	487.86	47.16
Operating Income	-171.81	-189.13	-210.17	-286.35	15.24
Interest Expense / Income	22.03	21.22	19.93	38.91	5.41
Other Expense / Income	-4.81	-3.77	2.63	44.59	1.96
Pretax Income	-189.04	-206.58	-232.73	-369.86	7.88
Income Tax	-15.92	-20.32	-17.17	-25.91	2.21
Net Income	-173.12	-186.26	-215.56	-343.95	5.67
Preferred Dividends	0	0	0	0	64.57
Net Income Common	-173.12	-186.26	-215.56	-343.95	-58.9
Shares Outstanding (Basic)	376	367	355	328	-
Shares Outstanding (Diluted)	376	367	355	328	-
Shares Change	4.28%	3.43%	8.47%	-	-
EPS (Basic)	-0.48	-0.51	-0.61	-1.05	-
EPS (Diluted)	-0.48	-0.51	-0.61	-1.05	-
Free Cash Flow	-68.73	-57.4	-26.47	-85.07	2.73
Free Cash Flow Per Share	-0.18	-0.16	-0.07	-0.26	-
Gross Margin	29.65%	28.62%	27.57%	30.19%	29.36%
Operating Margin	-15.57%	-17.92%	-24.45%	-42.90%	7.17%
Profit Margin	-15.69%	-17.64%	-25.08%	-51.53%	-27.72%
Free Cash Flow Margin	-6.23%	-5.44%	-3.08%	-12.74%	1.29%
Effective Tax Rate	-	-	-	-	28.01%
EBITDA	-43.51	-64.94	-105.44	-276.81	19.38
EBITDA Margin	-3.94%	-6.15%	-12.27%	-41.47%	9.12%
Depreciation & Amortization	123.49	120.42	107.36	54.14	6.1
EBIT	-167.01	-185.36	-212.8	-330.94	13.28
EBIT Margin	-15.13%	-17.56%	-24.76%	-49.58%	6.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).